Abstract
朗格汉斯细胞组织细胞增生症(LCH)是一种罕见的组织细胞肿瘤,儿童发病率为(3~5)/100万,成人发病率不足1/100万。LCH致死率低,但可引起严重的器官功能障碍。目前尚无公认针对成人患者的治疗推荐。自2013年欧洲组织细胞协会发布了成人LCH的管理建议以来,近年陆续报道了多项成人LCH队列研究。此外,随着丝裂原活化蛋白激酶(MAPK)途径中的基因突变陆续被发现,各种新型靶向药物也逐渐投入使用。本文就近10年成人LCH的治疗进展进行综述。.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.